Global Pharmaceutical and Biologics Regulatory Strategy, Second Edition

Member: $160.00 Nonmember: $225.00
Global Pharmaceutical and Biologics Regulatory Strategy, Second Edition

>> View Table of Contents

Understanding enhanced regulatory science and strategy and translating new discoveries into real-world products can make an enormous difference for individual and population health. However, doing so is fraught with challenges requiring coordinated work across disciplines, sectors and, increasingly, across nations. 

The new edition of Global Pharmaceutical and Biologics Regulatory Strategy outlines a systematic approach, spanning everything from the earliest stages of research and development to postmarketing, taking into account the challenges and realities of a global strategy to meet the requirements of multiple regulatory systems.

Updated by a group of distinguished regulatory experts, this second edition provides the essential elements of an integrated regulatory approach, including the ABCs of regulatory strategy and the whys and wherefores of interacting with regulators. Other chapters cover more technical aspects of the product lifecycle and regulatory oversight, such as preclinical and clinical development, expedited pathways, orphan designation, pediatric products, and product formulation, manufacturing and control.

Who Should Buy This Publication?

This new edition is a must-have handbook for regulatory professionals at all levels. It includes updated information as well as new insights to help you reach your strategic goals in a more effective and cost-efficient manner.

ISBN: 978-1-947493-41-4
Published by RAPS © 2020. Hardcover. 257 pages.

Add Book to Cart Add E-book to Cart

Discover more of what matters to you

Biologics Biotechnology Compliance Global Pharmaceuticals

News »